International drug policy panel calls for legalization of some drugs, de-criminalizing drug use

The Global Commission on Drug Policy - a panel that includes former U.N. Secretary-General Kofi Annan, Global Fund to Fight AIDS, Tuberculosis and Malaria Executive Director Michel Kazatchkine, and several other current and former world leaders - has released a report calling for "the legalization of some types of drugs and an end to the criminalization of drug users," The Voice of Russia reports (Vladimir, 6/2).

"In its 2011 report, the Global Commission endorses approaching drug use as a public health problem as well as examining alternatives to the incarceration of drug users, farmers, and petty sellers. But it also recommends more revolutionary approaches like decriminalisation of drug use and the possibility of legal regulation," Inter Press Service writes (Crowe, 6/2).


http://www.kaiserhealthnews.orgThis article was reprinted from kaiserhealthnews.org with permission from the Henry J. Kaiser Family Foundation. Kaiser Health News, an editorially independent news service, is a program of the Kaiser Family Foundation, a nonpartisan health care policy research organization unaffiliated with Kaiser Permanente.

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
Professor Nancy Ip: Pioneering New Paths in Neurodegenerative Therapy